Notch-RBP-J signaling is required by bone marrow stromal cells for the treatment of acute graft versus host disease

Stem Cell Research

Volumn 11, Issue 2, 2013, Pages 721-735

  Wang, Yao Chun ^a   Wang, Shu Hong ^b   Wei, Ya Ning ^c   Du, De Wei ^c   Xu, Hao ^c   Gao, Chun Chen ^c   Zheng, Min Hua ^c   Xie, Juan ^c   Li, Jun Chang ^c   Dong, Guang Ying ^c   Li, Li ^a   Xiao, Yang ^a   Han, Hua ^c  

^a GUANGZHOU GENERAL HOSPITAL OF GUANGZHOU MILITARY COMMAND   (China)

^b XI'AN JIAOTONG UNIVERSITY   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; NOTCH RECEPTOR; PROSTAGLANDIN E2;

ACUTE GRAFT VERSUS HOST DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; ARTICLE; BONE MARROW CELL; CELL ACTIVATION; CELL PROLIFERATION; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FEMALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STROMA CELL; WILD TYPE;

ACUTE DISEASE; ANIMALS; BONE MARROW TRANSPLANTATION; CELLS, CULTURED; FEMALE; FLOW CYTOMETRY; GRAFT VS HOST DISEASE; IMMUNOGLOBULIN J RECOMBINATION SIGNAL SEQUENCE-BINDING PROTEIN; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; RECEPTORS, NOTCH; SIGNAL TRANSDUCTION;

MAMMALIA; MURINAE;

EID: 84878784689     PISSN: 18735061     EISSN: 18767753     Source Type: Journal    
DOI: 10.1016/j.scr.2013.04.009     Document Type: Article

References (58)

1. Aggarwal S., Pittenger M.F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005, 105:1815-1822.
2. Artavanis-Tsakonas S., Rand M.D., Lake R.J. Notch signaling: cell fate control and signal integration in development. Science 1999, 284:770-776.
3. Bartholomew A., Sturgeon C., Siatskas M., Ferrer K., McIntosh K., Patil S., Hardy W., Devine S., Ucker D., Deans R., Moseley A., Hoffman R. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp. Hematol. 2002, 30:42-48.
4. Bianco P., Riminucci M., Gronthos S., Robey P.G. Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 2001, 19:180-192.
5. Bouffi C., Bony C., Courties G., Jorgensen C., Noël D. IL-6-dependent PGE2 secretion by mesenchymal stem cells inhibits local inflammation in experimental arthritis. PLoS One 2010, 5:e14247.
6. Boxall S.A., Jones E. Markers for characterization of bone marrow multipotential stromal cells. Stem Cells Int. 2012, 2012:975871.
7. Chiesa S., Morbelli S., Morando S., Massollo M., Marini C., Bertoni A., Frassoni F., Bartolomé S.T., Sambuceti G., Traggiai E., Uccelli A. Mesenchymal stem cells impair in vivo T-cell priming by dendritic cells. Proc. Natl. Acad. Sci. USA 2011, 108:17384-17389.
8. Daldrup-Link H.E., Rudelius M., Metz S., Piontek G., Pichler B., Settles M., Heinzmann U., Schlegel J., Oostendorp R.A., Rummeny E.J. Cell tracking with gadophrin-2: a bifunctional contrast agent for MR imaging, optical imaging, and fluorescence microscopy. Eur. J. Nucl. Med. Mol. Imaging 2004, 31:1312-1321.
9. Di Nicola M., Carlo-Stella C., Magni M., Milanesi M., Longoni P.D., Matteucci P., Grisanti S., Gianni A.M. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002, 99:3838-3843.
10. Djouad F., Charbonnier L.M., Bouffi C., Louis-Plence P., Bony C., Apparailly F., Cantos C., Jorgensen C., Noël D. Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism. Stem Cells 2007, 25:2025-2032.
11. Dong Y., Jesse A.M., Kohn A., Gunnell L.M., Honjo T., Zuscik M.J., O'Keefe R.J., Hilton M.J. RBPjkappa-dependent Notch signaling regulates mesenchymal progenitor cell proliferation and differentiation during skeletal development. Development 2010, 137:1461-1471.
12. Einstein O., Fainstein N., Vaknin I., Mizrachi-Kol R., Reihartz E., Grigoriadis N., Lavon I., Baniyash M., Lassmann H., Ben-Hur T. Neural precursors attenuate autoimmune encephalomyelitis by peripheral immunosuppression. Ann. Neurol. 2007, 61:209-218.
13. Fischer U.M., Harting M.T., Jimenez F., Monzon-Posadas W.O., Xue H., Savitz S.I., Laine G.A., Cox C.S. Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. Stem Cells Dev. 2009, 18:683-692.
14. Fitzpatrick F.A., Soberman R. Regulated formation of eicosanoids. J. Clin. Invest. 2001, 107:1347-1351.
15. Gao J., Dennis J.E., Muzic R.F., Lundberg M., Caplan A.I. The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells Tissues Organs 2001, 169:12-20.
16. Glennie S., Soeiro I., Dyson P.J., Lam E.W., Dazzi F. Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood 2005, 105:2821-2827.
17. Han H., Tanigaki K., Yamamoto N., Kuroda K., Yoshimoto M., Nakahata T., Ikuta K., Honjo T. Inducible gene knockout of transcription factor recombination signal binding protein-J reveals its essential role in T versus B lineage decision. Int. Immunol. 2002, 14:637-645.
18. Hasegawa H., Nomura T., Kohno M., Tateishi N., Suzuki Y., Maeda N., Fujisawa R., Yoshie O., Fujita S. Increased chemokine receptor CCR7/EBI1 expression enhances the infiltration of lymphoid organs by adult T-cell leukemia cells. Blood 2000, 95:30-38.
19. Jung Y.J., Ju S.Y., Yoo E.S., Cho S.J., Cho K.A., Woo S.Y., Seoh J.Y., Park J.W., Han H.S., Ryu K.H. MSC-DC interactions: MSC inhibit maturation and migration of BM-derived DC. Cytotherapy 2007, 9:451-458.
20. Kang W.J., Kang H.J., Kim H.S., Chung J.K., Lee M.C., Lee D.S. Tissue distribution of 18F-FDG-labeled peripheral hematopoietic stem cells after intracoronary administration in patients with myocardial infarction. J. Nucl. Med. 2006, 47:1295-1301.
21. Kishimoto T. IL-6: from its discovery to clinical applications. Int. Immunol. 2010, 22:347-352.
22. Korngold R., Sprent J. Surface markers of T cells causing lethal graft-vs-host disease to class I vs class II H-2 differences. J. Immunol. 1985, 135:3004-3010.
23. Kronsteiner B., Peterbauer-Scherb A., Grillari-Voglauer R., Redl H., Gabriel C., van Griensven M., Wolbank S. Human mesenchymal stem cells and renal tubular epithelial cells differentially influence monocyte-derived dendritic cell differentiation and maturation. Cell. Immunol. 2011, 267:30-38.
24. Kuhn R., Schwenk F., Aguet M., Rajewsky K. Inducible gene targeting in mice. Science 1995, 269:1427-1429.
25. Kumar K.S., Vijayan V., Bhaskar S., Krishnan K., Shalini V., Helen A. Anti-inflammatory potential of an ethyl acetate fraction isolated from Justicia gendarussa roots through inhibition of iNOS and COX-2 expression via NF-κB pathway. Cell. Immunol. 2012, 272:283-289.
26. Le Blanc K., Tammik L., Sundberg B., Haynesworth S.E., Ringdén O. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand. J. Immunol. 2003, 57:11-20.
27. Le Blanc K., Rasmusson I., Sundberg B., Götherström C., Hassan M., Uzunel M., Ringdén O. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004, 363:1439-1441.
28. Le Blanc K., Frassoni F., Ball L., Locatelli F., Roelofs H., Lewis I., Lanino E., Sundberg B., Bernardo M.E., Remberger M., Dini G., Egeler R.M., Bacigalupo A., Fibbe W., Ringdén O. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a Phase II study. Lancet 2008, 371:1579-1586.
29. Lee S.T., Chu K., Jung K.H., Kim S.J., Kim D.H., Kang K.M., Hong N.H., Kim J.H., Ban J.J., Park H.K., Kim S.U., Park C.G., Lee S.K., Kim M., Roh J.K. Antiinflammatory mechanism of intravascular neural stem cell transplantation in haemorrhagic stroke. Brain 2008, 131:616-629.
30. Lee R.H., Pulin A.A., Seo M.J., Kota D.J., Ylostalo J., Larson B.L., Semprun-Prieto L., Delafontaine P., Prockop D.J. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 2009, 5:54-63.
31. Li H., Guo Z., Jiang X., Zhu H., Li X., Mao N. Mesenchymal stem cells alter migratory property of T and dendritic cells to delay the development of murine lethal acute graft-versus-host disease. Stem Cells 2008, 26:2531-2541.
32. + hemopoietic progenitor cells to differentiate into regulatory dendritic cells through activation of the Notch pathway. J. Immunol. 2008, 180:1598-1608.
33. Libermann T.A., Baltimore D. Activation of interleukin-6 gene expression through the NF-kappa B transcription factor. Mol. Cell Biol. 1990, 10:2327-2334.
34. Miyake T., Inaba M., Fukui J., Ueda Y., Hosaka N., Kamiyama Y., Ikehara S. Prevention of graft-versus-host disease by intrabone marrow injection of donor T cells: involvement of bone marrow stromal cells. Clin. Exp. Immunol. 2008, 152:153-162.
35. +-derived and monocyte derived dendritic cells. J. Immunol. 2006, 177:2080-2087.
36. Osipo C., Golde T.E., Osborne B.A., Miele L.A. Off the beaten pathway: the complex cross talk between Notch and NF-kappaB. Lab. Invest. 2008, 88:11-17.
37. Palmieri M., Sasso M.P., Monese R., Merola M., Faggioli L., Tovey M., Furia A. Interaction of the nuclear protein CBF1 with the kappaB site of the IL-6 gene promoter. Nucleic Acids Res. 1999, 27:2785-2791.
38. Park S.J., Nakagawa T., Kitamura H., Atsumi T., Kamon H., Sawa S., Kamimura D., Ueda N., Iwakura Y., Ishihara K., Murakami M., Hirano T. IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation. J. Immunol. 2004, 173:3844-3854.
39. Plaisance S., Vanden Berghe W., Boone E., Fiers W., Haegeman G. Recombination signal sequence binding protein Jkappa is constitutively bound to the NF-kappaB site of the interleukin-6 promoter and acts as a negative regulatory factor. Mol. Cell Biol. 1997, 17:3733-3743.
40. Rochefort G.Y., Vaudin P., Bonnet N., Pages J.C., Domenech J., Charbord P., Eder V. Influence of hypoxia on the domiciliation of mesenchymal stem cells after infusion into rats: possibilities of targeting pulmonary artery remodeling via cells therapies?. Respir. Res. 2005, 6:125.
41. Sacchetti B., Funari A., Michienzi S., Di Cesare S., Piersanti S., Saggio I., Tagliafico E., Ferrari S., Robey P.G., Riminucci M., Bianco P. Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 2007, 131:324-336.
42. Schrepfer S., Deuse T., Reichenspurner H., Fischbein M.P., Robbins R.C., Pelletier M.P. Stem cell transplantation: the lung barrier. Transplant. Proc. 2007, 39:573-576.
43. Schroeder M.A., DiPersio J.F. Mouse models of graft-versus-host disease: advances and limitations. Dis. Model. Mech. 2011, 4:318-333.
44. Spaggiari G.M., Abdelrazik H., Becchetti F., Moretta L. MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2. Blood 2009, 113:6576-6583.
45. Spencer N.D., Gimble J.M., Lopez M.J. Mesenchymal stromal cells: past, present, and future. Vet. Surg. 2011, 40:129-139.
46. Suzuki S., Noda M., Akaizawa T., Song C., Tsubochi H., Suzuki T., Fujimura S. Intact alveolar epithelial permeability and transalveolar fluid absorption after thoracic irradiation in rats. Radiat. Res. 1999, 152:517-522.
47. Trento C., Dazzi F. Mesenchymal stem cells and innate tolerance: biology and clinical applications. Swiss Med. Wkly. 2010, 140:w13121.
48. Tse W.T., Pendleton J.D., Beyer W.M., Egalka M.C., Guinan E.C. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 2003, 75:389-397.
49. Viola A., Contento L.V., Molon B. T cells and their partners: the chemokine dating agency. Trends Immunol. 2006, 27:421-427.
50. Wang Y.C., Hu X.B., He F., Feng F., Wang L., Li W., Zhang P., Li D., Jia Z.S., Liang Y.M., Han H. Lipopolysaccharide-induced maturation of bone marrow-derived dendritic cells is regulated by Notch signaling through the up-regulation of CXCR4. J. Biol. Chem. 2009, 284:15993-16003.
51. Wang P., Zhu F., Konstantopoulos K. Prostaglandin E2 induces interleukin-6 expression in human chondrocytes via cAMP/protein kinase A- and phosphatidylinositol 3-kinase-dependent NF-kappaB activation. Am. J. Physiol. Cell Physiol. 2010, 298:C1445-C1456.
52. Wang Y.C., He F., Feng F., Liu X.W., Dong G.Y., Qin H.Y., Hu X.B., Zheng M.H., Liang L., Feng L., Liang Y.M., Han H. Notch signaling determines the M1 versus M2 polarization of macrophages in antitumor immune responses. Cancer Res. 2010, 70:4840-4849.
53. Weng J.Y., Du X., Geng S.X., Peng Y.W., Wang Z., Lu Z.S., Wu S.J., Luo C.W., Guo R., Ling W., Deng C.X., Liao P.J., Xiang A.P. Mesenchymal stem cell as salvage treatment for refractory chronic GVHD. Bone Marrow Transplant. 2010, 45:1732-1740.
54. Wongchana W., Palaga T. Direct regulation of interleukin-6 expression by Notch signaling in macrophages. Cell. Mol. Immunol. 2012, 9:155-162.
55. Xie J., Wang W., Si J.W., Miao X.Y., Li J.C., Wang Y.C., Wang Z.R., Ma J., Zhao X.C., Li Z., Yi H., Han H. Notch signaling regulates CXCR4 expression and the migration of mesenchymal stem cells. Cell. Immunol. 2013, 281:68-75.
56. Yagi H., Soto-Gutierrez A., Parekkadan B., Kitagawa Y., Tompkins R.G., Kobayashi N., Yarmush M.L. Mesenchymal stem cells: mechanisms of immunomodulation and homing. Cell Transplant. 2010, 19:667-679.
57. Yeh T.S., Wu C.W., Hsu K.W., Liao W.J., Yang M.C., Li A.F., Wang A.M., Kuo M.L., Chi C.W. The activated Notch1 signal pathway is associated with gastric cancer progression through cyclooxygenase-2. Cancer Res. 2009, 69:5039-5048.
58. Zhang B., Liu R., Shi D., Liu X., Chen Y., Dou X., Zhu X., Lu C., Liang W., Liao L., Zenke M., Zhao R.C. Mesenchymal stem cells induce mature dendritic cells into a novel Jagged-2-dependent regulatory dendritic cell population. Blood 2009, 113:46-57.